COVID-19: CDC, FDA and CMS Guidance

Nov 17, 2020
The recently launched AHA Living Learning Network (LLN) provides essential resources through a peer-to-peer community of health care professionals dedicated to helping hospitals and health systems recover, rebuild and reimagine health care while responding to the pandemic.
Nov 16, 2020
The AHA will host a call today, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.
Nov 10, 2020
The Food and Drug Administration Nov. 10 issued an emergency use authorization for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab.
Nov 9, 2020
The House of Representatives approved the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800) on May 15, 2020, and an updated version on Sept. Both bills included the COVID-19 Every Worker First Protection Act of 2020, which would require new Occupational Safety and…
Nov 9, 2020
The Food and Drug Administration issued an emergency use authorization for the first serology test to identify individuals with neutralizing antibodies from recent or prior infection with the virus that causes COVID-19.
Nov 9, 2020
The Department of Health and Human Services should fully reinstate its June COVID-19 Provider Relief Fund reporting requirements, AHA said again today in a letter to the agency.
Nov 5, 2020
The Centers for Disease Control and Prevention updated its recommended practices to prevent and control infection in health care settings during the COVID-19 pandemic. 
Nov 4, 2020
Pregnant women with COVID-19 are more likely than their non-pregnant counterparts to be admitted to an intensive care unit, receive invasive ventilation, extracorporeal membrane oxygenation or die, according to a study of 461,825 women with symptomatic COVID-19 released by the Centers for Disease…